Dr. Paul's project is aimed at testing a novel hypothesis related to the function of MeCP2. The investigator's preliminary data presents an entirely new facet of MeCP2 function which is that MeCP2 can function by binding directly to messenger RNA (mRNA) and potentially regulates the synthesis of downstream proteins. The project may provide new insights into the role of MeCP2 and mRNA is an ideal target for drug discovery because it is a key regulatory molecule in the cell.
|Effective start/end date||1/1/09 → 1/1/11|
- International Rett Syndrome Foundation
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.